A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study

被引：0
|
作者：
Xin Tang
Yuan Li
Wen-lei Qian
Wei-feng Yan
Tong Pang
You-ling Gong
Zhi-gang Yang
机构：
[1] West China Hospital,Department of Radiology
[2] Sichuan University,Department of Thoracic Oncology and State Key Laboratory of Biotherapy, Cancer Center
[3] West China Hospital,undefined
[4] Sichuan University,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Osimertinib; EGFR-T790M; Non-small cell lung cancer; Prognostic analysis; Real-world study;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2475 / 2486
页数：11
相关论文
共 50 条
  • [1] A comprehensive prognostic analysis of osimertinib treatment in advanced non-small cell lung cancer patients with acquired EGFR-T790M mutation: a real-world study
    Tang, Xin
    Li, Yuan
    Qian, Wen-lei
    Yan, Wei-feng
    Pang, Tong
    Gong, You-ling
    Yang, Zhi-gang
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (09) : 2475 - 2486
  • [2] Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
    Yamada, T.
    Yoshimura, A.
    Takeda, T.
    Shiotsu, S.
    Hiranuma, O.
    Chihara, Y.
    Uchino, J.
    Takayama, K.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1033 - S1033
  • [3] Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation
    Yoshimura, Akihiro
    Yamada, Tadaaki
    Okura, Naoko
    Takeda, Takayuki
    Hirose, Kazuki
    Kubota, Yutaka
    Shiotsu, Shinsuke
    Hiranuma, Osamu
    Chihara, Yusuke
    Tamiya, Nobuyo
    Kaneko, Yoshiko
    Uchino, Junji
    Takayama, Koichi
    CANCERS, 2019, 11 (03)
  • [4] Real-world osimertinib for EGFR mutation-positive non-small-cell lung cancer with acquired T790M mutation
    Imamura, Fumio
    Kimura, Madoka
    Yano, Yukihiro
    Mori, Masahide
    Suzuki, Hidekazu
    Hirashima, Tomonori
    Ihara, Shouichi
    Komuta, Kiyoshi
    Shiroyama, Takayuki
    Nagatomo, Izumi
    Kumagai, Toru
    FUTURE ONCOLOGY, 2020, 16 (21) : 1537 - 1546
  • [5] Real-World Data on Osimertinib in Chinese Patients with Pretreated, EGFR T790M Mutation Positive, Advanced Non-Small Cell Lung Cancer: A Retrospective Study
    Peng, Da
    Shan, Dongfeng
    Dai, Chengcheng
    Li, Jie
    Wang, Zifan
    Huang, Ziyi
    Peng, Rui
    Zhao, Peng
    Ma, Xuezhen
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 2033 - 2039
  • [6] Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer
    Bertranou, Evelina
    Bodnar, Carolyn
    Dansk, Viktor
    Greystoke, Alastair
    Large, Samuel
    Dyer, Matthew
    JOURNAL OF MEDICAL ECONOMICS, 2018, 21 (02) : 113 - 121
  • [7] Phase II trial of alternating osimertinib with gefitinib in patients with EGFR-T790M mutation positive advanced non-small cell lung cancer (Oscillate)
    Mersiades, Antony
    Pavlakis, Nick
    Kao, Steven
    John, Tom
    Lee, Chee Khoon
    Dawson, Sarah-Jane
    Wong, Stephen
    Tan, Lavinia
    Yip, Sonia
    Brown, Chris
    Livingstone, Ann
    Cheung, Yvonne
    Jurkovic, Hannora
    Stockler, Martin
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 : 199 - 200
  • [8] Real-world analysis of the EGFR T790M mutation in plasma and tissue biopsy from advanced non-small cell lung cancer
    Lee, Eun Hye
    Kwak, Se Hyun
    Kim, Chi Young
    Lee, Sang Hoon
    Kim, Eun Young
    Chang, Yoon Soo
    RESPIROLOGY, 2023, 28 : 99 - 100
  • [9] Real-World Study of Osimertinib in EGFR T790M-Mutated Non-Small Cell Lung Cancer (NSCLC): ASTRIS Canadian Cohort Analysis
    Cheema, P.
    Liu, G.
    Burkes, R.
    Owen, S.
    Yu, J.
    Hao, D.
    Rothenstein, J.
    Martel, S.
    Iqbal, M.
    Juergens, R.
    Lam, W.
    Laskin, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S803 - S803
  • [10] ASTRIS: A real world treatment study of osimertinib in patients (pts) with EGFR T790M positive non-small cell lung cancer (NSCLC).
    De Marinis, Filippo
    Cho, Byoung Chul
    Kim, Dong-Wan
    Kim, Sang-We
    Hochmair, Maximilian J.
    Metro, Giulio
    Vansteenkiste, Johan F.
    Vicente, David
    Solomon, Benjamin J.
    Cheema, Parneet K.
    Freitas, Helano C.
    Provencio, Mariano
    Chen, Yuh-Min
    Wu, Yi-Long
    Milner, Alvin
    Rigas, James R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345